p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy

doi:10.3748/wjg.v11.i36.5696

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2917)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

215

HTML

2240

Figures (1-2)

275

Tables (1-4)

187

Sum=2917

Sep 28, 2005 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Sep 28, 2005; 11(36): 5696-5700
Published online Sep 28, 2005. doi: 10.3748/wjg.v11.i36.5696

Full Size Figure Download Figure

Figure 2 Relation between survival rates of 36 patients and staging of esophageal cancer. No significant difference was seen between survival curves of the p53-negative and p53-positive patients and esophageal cancer staging.

Citation: Sunada F, Itabashi M, Ohkura H, Okumura T. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy. World J Gastroenterol 2005; 11(36): 5696-5700
URL: https://www.wjgnet.com/1007-9327/full/v11/i36/5696.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i36.5696